Home LiteratureArticle Details
PMID: 15838328 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Transforming growth factor-beta induces endothelin-1 expression through activation of the Smad signaling pathway.

Journal of cardiovascular pharmacology ·Vol. 44 Suppl 1 ·2004-11-00 ·Pages S39-42

Rodríguez-Pascual F, Reimunde FM, Redondo-Horcajo M, Lamas S

Abstract

Expression of the endothelin-1 gene is subject to complex regulation by different factors, among which transforming growth factor-beta is one of the most important. We have analyzed the mechanism by which transforming growth factor-beta increases endothelin-1 expression in vascular endothelial cells. Transcriptional activation of the endothelin-1 promoter accounted for the transforming growth factor-beta-induced increase in endothelin-1 mRNA levels. Two DNA elements within the promoter are responsible for this effect: a Smad binding element and a proximal activator protein-1 site. Mutation of both elements abolished transforming growth factor-beta responsiveness. Overexpression of the Smad3 isoform strongly potentiates transforming growth factor-beta- induced endothelin-1 promoter activity in a phosphorylation-dependent manner. These results demonstrate that transforming growth factor-beta induces endothelin-1 expression by a functional cooperation between Smads and activator protein-1 through activation of the Smad signaling pathway.

MeSH Terms
Animals Cattle Cells, Cultured Endothelial Cells/metabolism Endothelin-1/genetics,metabolism Humans Mutation Phosphorylation Promoter Regions, Genetic Recombinant Proteins/metabolism Signal Transduction/genetics Smad3 Protein/genetics,metabolism Time Factors Transcription Factor AP-1/metabolism Transcriptional Activation Transfection Transforming Growth Factor beta1/metabolism Up-Regulation
Chemicals
Endothelin-1 Recombinant Proteins Smad3 Protein Transcription Factor AP-1 Transforming Growth Factor beta1
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Rodríguez-Pascual Fernando
Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, C.S.I.C., Instituto Reina Sofía de Investigaciones Nefrológicas, Madrid, Spain. frodriguez@cib.csic.es
Reimunde Francisco Manuel
Redondo-Horcajo Mariano
Lamas Santiago
Article Info
Journal
Journal of cardiovascular pharmacology
Abbr.
J Cardiovasc Pharmacol
ISSN
1533-4023
Published
2004-11-00
Pages
S39-42
Language
English
Region
United States
NLM ID
7902492
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com